Hospital market analysis: Post-COVID belt-tightening, M&A activity likely ahead

If they hope to survive the COVID healthcare economy, many independent hospitals may need to cut their workforces, slash their expenses, reduce their investments, pull the plug on some clinical service lines—or all of the above.

That’s among the conclusions detailed in a new report written by analysts with the Waller law firm and the financial consultancy KaufmanHall.

The combination of scaled-back elective procedures and ballooned PPE purchasing helps explain why more than a quarter of U.S. hospital systems had used up more than 50% of their liquid reserves by mid-June, the authors note.

On the other side of the coin, the pandemic has revealed that some health systems are poised for growth.  

“Ultimately, larger systems are better positioned for the future,” the authors write. “With higher revenues and access to assets to pledge as collateral, larger systems have obtained debt financing in greater amounts and on more favorable terms than their smaller counterparts.”

From this observation the authors predict a surge in M&A deals after COVID relents, releasing considerable pent-up demand.

However, that road may be rocky regardless of would-be buyers’ market strength.

“Although larger hospital systems are better suited to withstand the liquidity challenges of the pandemic than smaller and rural systems, they too are facing strains on their liquidity,” the authors point out. “This financial pressure is likely to reduce the number of potential buyers in the market even as many smaller systems seek out strategic transactions.”

The report is available in full for free (PDF).

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”